Heterogeneity	O
of	O
antigen	B-protein
molecules	I-protein
recognized	O
by	O
anti-tax1	B-protein
monoclonal	I-protein
antibody	I-protein
Lt-4	B-protein
in	O
cell	O
lines	O
bearing	O
human	O
T	O
cell	O
leukemia	O
virus	O
type	O
I	O
and	O
related	O
retroviruses	O
.	O

Using	O
a	O
monoclonal	B-protein
antibody	I-protein
,	O
Lt-4	B-protein
,	O
directed	O
against	O
human	B-protein
T	I-protein
cell	I-protein
leukemia	I-protein
virus	I-protein
type	I-protein
I	I-protein
(	I-protein
HTLV-I	I-protein
)	I-protein
trans-activator	I-protein
(	I-protein
tax1	I-protein
)	I-protein
antigen	I-protein
,	O
we	O
examined	O
the	O
expression	O
of	O
tax1	B-protein
and	O
related	O
antigens	B-protein
in	O
a	O
variety	O
of	O
T	B-cell_line
cell	I-cell_line
lines	I-cell_line
bearing	O
HTLV-I	O
and	O
related	O
retroviruses	O
,	O
simian	O
T	O
cell	O
leukemia	O
virus	O
type	O
I	O
(	O
STLV-I	O
)	O
and	O
HTLV-II	O
,	O
by	O
immunofluorescence	O
and	O
immunoblot	O
assays	O
.	O

Lt-4	B-protein
reacted	O
with	O
all	O
HTLV-I-bearing	B-cell_line
cell	I-cell_line
lines	I-cell_line
tested	O
and	O
five	O
out	O
of	O
eight	O
simian	B-cell_line
cell	I-cell_line
lines	I-cell_line
bearing	O
STLV-I	O
,	O
but	O
not	O
with	O
an	O
HTLV-II-bearing	B-cell_line
cell	I-cell_line
line	I-cell_line
.	O

Lt-4	B-protein
detected	O
40	O
kd	O
tax1	B-protein
antigen	I-protein
molecules	I-protein
in	O
most	O
HTLV-I-bearing	B-cell_line
cell	I-cell_line
lines	I-cell_line
except	O
one	O
cell	O
line	O
that	O
expressed	O
39	B-protein
kd	I-protein
tax1	I-protein
antigen	I-protein
.	O

In	O
the	O
STLV-I-bearing	B-cell_line
T	I-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
tax1-related	B-protein
antigen	I-protein
molecules	I-protein
detected	O
by	O
Lt-4	B-protein
were	O
heterogeneous	O
,	O
having	O
molecular	O
weights	O
in	O
the	O
range	O
of	O
36-41	O
kd	O
.	O

Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

81	NULL
,	NULL
225-231	NULL
,	NULL
March	NULL
1990	NULL
Heterogeneity	NULL
of	NULL
Antigen	NULL
Molecules	NULL
Recognized	NULL
by	NULL
Anti-tax	NULL
,	NULL
Monoclonal	NULL
Antibody	NULL
Lt-4	NULL
in	NULL
Cell	NULL
Lines	NULL
Bearing	NULL
Human	NULL
T	NULL
Cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
I	NULL
and	NULL
Related	NULL
Retroviruses	NULL
Yuetsu	NULL
Tanaka	NULL
,	NULL
``	NULL
Atsushi	NULL
Yoshida	NULL
,	NULL
'	NULL
Yoshinaga	NULL
Takayama	NULL
,	NULL
``	NULL
Hajime	NULL
Tsujimoto	NULL
,	NULL
``	NULL
Atsumi	NULL
Tsujimoto	NULL
,	NULL
``	NULL
Masanori	NULL
Hayami®	NULL
and	NULL
Hideki	NULL
Tozawa	NULL
'	NULL
'Department	NULL
of	NULL
Immunology	NULL
,	NULL
School	NULL
of	NULL
Hygienic	NULL
Sciences	NULL
,	NULL
Kitasato	NULL
University	NULL
,	NULL
15-1	NULL
Kitasato	NULL
I-chome	NULL
,	NULL
Sagamihara	NULL
,	NULL
Kanagawa	NULL
228	NULL
,	NULL
'Department	NULL
of	NULL
Animal	NULL
Pathology	NULL
,	NULL
Institute	NULL
of	NULL
Medical	NULL
Science	NULL
,	NULL
The	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
Shiroganedai	NULL
,	NULL
Minato-ku	NULL
,	NULL
Tokyo	NULL
108	NULL
,	NULL
``	NULL
Virology	NULL
Division	NULL
,	NULL
National	NULL
Cancer	NULL
Center	NULL
Research	NULL
Institute	NULL
,	NULL
Tsukiji	NULL
Chuo-ku	NULL
,	NULL
Tokyo	NULL
104	NULL
and	NULL
Institute	NULL
for	NULL
Virus	NULL
Research	NULL
,	NULL
Kyoto	NULL
University	NULL
,	NULL
Shogoin	NULL
,	NULL
Sakyo-ku	NULL
,	NULL
Kyoto	NULL
606	NULL
Using	NULL
a	NULL
monoclonal	NULL
antibody	NULL
,	NULL
Lt-4	NULL
,	NULL
directed	NULL
against	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-D	NULL
transactivator	NULL
(	NULL
tax	NULL
,	NULL
)	NULL
antigen	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
expression	NULL
of	NULL
tax	NULL
,	NULL
and	NULL
related	NULL
antigens	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
T	NULL
cell	NULL
lines	NULL
bearing	NULL
HTLV-I	NULL
and	NULL
related	NULL
retroviruses	NULL
,	NULL
simian	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
STLYV-D	NULL
and	NULL
HTLV-II	NULL
,	NULL
by	NULL
immunofluorescence	NULL
and	NULL
immunoblot	NULL
assays	NULL
.	NULL

Lt-4	NULL
reacted	NULL
with	NULL
all	NULL
HTLV-I-bearing	NULL
cell	NULL
lines	NULL
tested	NULL
and	NULL
five	NULL
out	NULL
of	NULL
eight	NULL
simian	NULL
cell	NULL
lines	NULL
bearing	NULL
STLV-LI	NULL
,	NULL
but	NULL
not	NULL
with	NULL
an	NULL
HTLV-II-bear-ing	NULL
cell	NULL
line	NULL
.	NULL

Lt-4	NULL
detected	NULL
40	NULL
kd	NULL
tax	NULL
,	NULL
antigen	NULL
molecules	NULL
in	NULL
most	NULL
HTLV-I-bearing	NULL
cell	NULL
lines	NULL
except	NULL
one	NULL
cell	NULL
line	NULL
that	NULL
expressed	NULL
39	NULL
kd	NULL
tax	NULL
,	NULL
antigen	NULL
.	NULL

In	NULL
the	NULL
STLV-I-bearing	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
tax	NULL
,	NULL
-related	NULL
antigen	NULL
molecules	NULL
detected	NULL
by	NULL
Lt-4	NULL
were	NULL
heterogeneous	NULL
,	NULL
having	NULL
molecular	NULL
weights	NULL
in	NULL
the	NULL
range	NULL
of	NULL
36-41	NULL
kd	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
Human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
}	NULL
®	NULL
is	NULL
a	NULL
C-type	NULL
retrovirus	NULL
etiologically	NULL
associated	NULL
with	NULL
a	NULL
human	NULL
malignant	NULL
T	NULL
cell	NULL
disorder	NULL
,	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
(	NULL
ATL	NULL
}	NULL
.	NULL

*	NULL
``	NULL
The	NULL
HTLV-I	NULL
genome	NULL
contains	NULL
open	NULL
reading	NULL
frames	NULL
for	NULL
viral	NULL
structural	NULL
components	NULL
,	NULL
gag	NULL
,	NULL
pol	NULL
and	NULL
eny	NULL
and	NULL
a	NULL
unique	NULL
sequence	NULL
termed	NULL
pX	NULL
encoding	NULL
three	NULL
non-structural	NULL
proteins	NULL
.	NULL
``	NULL

One	NULL
antigen	NULL
called	NULL
p40	NULL
``	NULL
,	NULL
or	NULL
tax	NULL
,	NULL
antigen	NULL
,	NULL
acts	NULL
as	NULL
a	NULL
frans-activator	NULL
(	NULL
tax	NULL
)	NULL
of	NULL
the	NULL
HTLV-I	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
and	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
transformation	NULL
and	NULL
immortalization	NULL
of	NULL
normal	NULL
T	NULL
cells	NULL
infected	NULL
with	NULL
HTLV-I	NULL
,	NULL
because	NULL
the	NULL
tax	NULL
;	NULL
antigen	NULL
activates	NULL
the	NULL
cellular	NULL
genes	NULL
encoding	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
and	NULL
IL-2	NULL
receptor	NULL
which	NULL
are	NULL
essential	NULL
for	NULL
T	NULL
cell	NULL
growth	NULL
.	NULL
``	NULL

''	NULL
Natural	NULL
antibodies	NULL
to	NULL
HTLV-I	NULL
gag	NULL
and/or	NULL
eny	NULL
antigens	NULL
are	NULL
found	NULL
in	NULL
almost	NULL
all	NULL
sera	NULL
from	NULL
HTLV-I-infected	NULL
humans	NULL
,	NULL
``	NULL
~	NULL
``	NULL
whereas	NULL
anti-tax	NULL
,	NULL
antibodies	NULL
are	NULL
found	NULL
in	NULL
only	NULL
one-third	NULL
of	NULL
the	NULL
sera	NULL
.	NULL
'	NULL

''	NULL
Although	NULL
the	NULL
protein	NULL
structure	NULL
of	NULL
the	NULL
tax	NULL
,	NULL
antigen	NULL
has	NULL
been	NULL
deduced	NULL
from	NULL
the	NULL
nucleotide	NULL
sequence	NULL
,	NULL
``	NULL
little	NULL
is	NULL
known	NULL
about	NULL
its	NULL
antigenic	NULL
structure	NULL
.	NULL

With	NULL
antisera	NULL
against	NULL
synthetic	NULL
peptides	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
the	NULL
tax	NULL
;	NULL
antigen	NULL
expressed	NULL
antigenic	NULL
determinants	NULL
in	NULL
the	NULL
C-	NULL
and/	NULL
or	NULL
N-terminal	NULL
regions	NULL
which	NULL
cross-reacted	NULL
with	NULL
other	NULL
tax	NULL
antigens	NULL
encoded	NULL
by	NULL
other	NULL
retroviruses	NULL
of	NULL
the	NULL
HTLV-I	NULL
>	NULL
To	NULL
whom	NULL
all	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

**	NULL
Present	NULL
address	NULL
:	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
Garscube	NULL
Estate	NULL
,	NULL
Switchback	NULL
Road	NULL
,	NULL
Bearsden	NULL
,	NULL
Glasgow	NULL
G61	NULL
1BD	NULL
,	NULL
UK	NULL
.	NULL

®	NULL
Abbreviations	NULL
:	NULL
HTLV-I	NULL
,	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
;	NULL
STLY-I	NULL
,	NULL
simian	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
;	NULL
HTLV-II	NULL
,	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
II	NULL
;	NULL
tax	NULL
,	NULL
trans-activator	NULL
.	NULL

HTLV-I	NULL
--	NULL
STLV-	NULL
-	NULL
HTLV-II	NULL
-	NULL
trans	NULL
Activator	NULL
antigen	NULL
-	NULL
Monoclonal	NULL
antibody	NULL
family	NULL
,	NULL
``	NULL
'	NULL
%	NULL
``	NULL
``	NULL
simian	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
STLV-I	NULL
)	NULL
isolated	NULL
from	NULL
several	NULL
species	NULL
of	NULL
Old	NULL
World	NULL
monkeys*'~	NULL
``	NULL
and	NULL
HTLY	NULL
type	NULL
II	NULL
(	NULL
HTLV-II	NULL
)	NULL
isolated	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
hairy	NULL
cell	NULL
leukemia	NULL
.	NULL
``	NULL

The	NULL
putative	NULL
tax	NULL
antigens	NULL
of	NULL
some	NULL
strains	NULL
of	NULL
STLY-I	NULL
and	NULL
the	NULL
tax	NULL
antigen	NULL
of	NULL
HTLV-II	NULL
(	NULL
tax	NULL
;	NULL
)	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
protein	NULL
molecules	NULL
of	NULL
about	NULL
41	NULL
kd	NULL
``	NULL
``	NULL
and	NULL
about	NULL
38	NULL
kd	NULL
,	NULL
respec-tively	NULL
.	NULL
``	NULL

''	NULL
``	NULL
However	NULL
,	NULL
no	NULL
report	NULL
has	NULL
compared	NULL
the	NULL
tax	NULL
antigen	NULL
molecules	NULL
expressed	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
bearing	NULL
HTLV-I	NULL
,	NULL
STLYV-I	NULL
and	NULL
HTLV-II	NULL
by	NULL
using	NULL
either	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
mAbs	NULL
}	NULL
*	NULL
``	NULL
or	NULL
monospecific	NULL
antisera	NULL
to	NULL
tax	NULL
antigen	NULL
peptides	NULL
.	NULL

To	NULL
study	NULL
further	NULL
the	NULL
antigenic	NULL
structure	NULL
of	NULL
the	NULL
tax	NULL
;	NULL
antigen	NULL
,	NULL
preparation	NULL
of	NULL
mAbs	NULL
against	NULL
various	NULL
epitopes	NULL
of	NULL
the	NULL
antigen	NULL
is	NULL
essential	NULL
,	NULL
but	NULL
a	NULL
library	NULL
of	NULL
mAbs	NULL
to	NULL
the	NULL
tax	NULL
;	NULL
antigen	NULL
has	NULL
not	NULL
been	NULL
established	NULL
.	NULL

Recently	NULL
we	NULL
succeeded	NULL
in	NULL
the	NULL
preparation	NULL
of	NULL
a	NULL
mAb	NULL
reactive	NULL
with	NULL
the	NULL
tax	NULL
;	NULL
antigen	NULL
,	NULL
Lt-4	NULL
,	NULL
from	NULL
mice	NULL
immunized	NULL
with	NULL
purified	NULL
native	NULL
tax	NULL
;	NULL
antigen	NULL
.	NULL
``	NULL

''	NULL
The	NULL
present	NULL
study	NULL
was	NULL
designed	NULL
to	NULL
determine	NULL
the	NULL
Lt-4	NULL
reactivity	NULL
with	NULL
various	NULL
cell	NULL
lines	NULL
expressing	NULL
transactivator	NULL
antigens	NULL
of	NULL
HTLV-I	NULL
,	NULL
STLYV-I	NULL
and	NULL
HTLYV-II	NULL
,	NULL
because	NULL
such	NULL
studies	NULL
may	NULL
be	NULL
helpful	NULL
in	NULL
revealing	NULL
the	NULL
antigenicity	NULL
of	NULL
not	NULL
only	NULL
the	NULL
tax	NULL
,	NULL
antigen	NULL
but	NULL
also	NULL
the	NULL
tax	NULL
antigens	NULL
encoded	NULL
by	NULL
STLV-I	NULL
and	NULL
HTLV-II	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
found	NULL
that	NULL
Lt-4	NULL
reacted	NULL
with	NULL
all	NULL
HTLYVY-I-bearing	NULL
cell	NULL
lines	NULL
tested	NULL
and	NULL
detected	NULL
40	NULL
kd	NULL
tax	NULL
,	NULL
antigen	NULL
molecules	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
except	NULL
one	NULL
that	NULL
expressed	NULL
39	NULL
kd	NULL
tax	NULL
,	NULL
antigen	NULL
.	NULL

Lt-4	NULL
also	NULL
reacted	NULL
with	NULL
some	NULL
STLYV-I	NULL
strain-bearing	NULL
cell	NULL
lines	NULL
,	NULL
but	NULL
not	NULL
with	NULL
an	NULL
HTLYV-II-bearing	NULL
cell	NULL
line	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
Lt-	NULL
4	NULL
-reactive	NULL
225	NULL
Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

81	NULL
,	NULL
March	NULL
1990	NULL
tax-related	NULL
antigen	NULL
molecules	NULL
expressed	NULL
in	NULL
the	NULL
STLY-I-bearing	NULL
cell	NULL
lines	NULL
were	NULL
heterogeneous	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
The	NULL
cell	NULL
lines	NULL
bearing	NULL
HTLV-I	NULL
,	NULL
STLY-I	NULL
and	NULL
HTLV-II	NULL
are	NULL
listed	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

These	NULL
cell	NULL
lines	NULL
were	NULL
cultured	NULL
in	NULL
RPMI1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10-15	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
100	NULL
units/ml	NULL
penicillin	NULL
and	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
20	NULL
units/ml	NULL
human	NULL
recombinant	NULL
IL-2	NULL
(	NULL
Shionogi	NULL
,	NULL
Osaka	NULL
)	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
humidified	NULL
air	NULL
,	NULL
.	NULL

These	NULL
cell	NULL
lines	NULL
were	NULL
passaged	NULL
twice	NULL
a	NULL
week	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
-	NULL
HTLYV-I-specific	NULL
mAbs	NULL
used	NULL
were	NULL
GIN-14	NULL
,	NULL
anti-gag	NULL
p19	NULL
;	NULL
NOR-1	NULL
,	NULL
anti-gag	NULL
p24	NULL
;	NULL
FR-45	NULL
,	NULL
anti-gag	NULL
p15	NULL
and	NULL
TA-21	NULL
,	NULL
anti-env	NULL
gp21	NULL
.	NULL

``	NULL
``	NULL
~	NULL
``	NULL
``	NULL
A	NULL
mouse	NULL
IgG	NULL
mAb	NULL
,	NULL
Lt-4	NULL
,	NULL
was	NULL
prepared	NULL
recently	NULL
from	NULL
mice	NULL
immunized	NULL
with	NULL
affinity-purified	NULL
tax	NULL
;	NULL
,	NULL
antigen	NULL
from	NULL
an	NULL
HTLV-I-bearing	NULL
cell	NULL
line	NULL
by	NULL
using	NULL
rabbit	NULL
IgG	NULL
anti-tax	NULL
;	NULL
peptide	NULL
,	NULL
and	NULL
was	NULL
determined	NULL
to	NULL
be	NULL
specific	NULL
for	NULL
human	NULL
HTLV-I-bearing	NULL
T	NULL
cell	NULL
lines	NULL
and	NULL
to	NULL
recognize	NULL
the	NULL
tax	NULL
;	NULL
antigen	NULL
,	NULL
p40*	NULL
.	NULL

*	NULL
``	NULL
Immunofluorescence	NULL
-	NULL
Cells	NULL
were	NULL
smeared	NULL
onto	NULL
glass	NULL
slides	NULL
,	NULL
fixed	NULL
with	NULL
methanol	NULL
,	NULL
and	NULL
stained	NULL
by	NULL
an	NULL
indirect	NULL
immunofluorescence	NULL
(	NULL
IF	NULL
)	NULL
method	NULL
using	NULL
mAbs	NULL
and	NULL
FITC-labeled	NULL
goat	NULL
IgG	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
Cappel	NULL
,	NULL
PA	NULL
)	NULL
as	NULL
the	NULL
secondary	NULL
reagent	NULL
.	NULL

Immunoblot	NULL
-	NULL
Immunoblot	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
cell	NULL
lysates	NULL
,	NULL
which	NULL
were	NULL
obtained	NULL
by	NULL
lysis	NULL
of	NULL
cells	NULL
with	NULL
a	NULL
low	NULL
salt	NULL
extraction	NULL
buffer	NULL
(	NULL
10	NULL
m¥	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
containing	NULL
0.14	NULL
M	NULL
NaCl	NULL
,	NULL
3	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
2	NULL
mM	NULL
phenylmethyl-sulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
NP4O0	NULL
)	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
centrifugation	NULL
at	NULL
12,000g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
on	NULL
10	NULL
%	NULL
separation	NULL
gels	NULL
,	NULL
and	NULL
blotted	NULL
electrophoretically	NULL
onto	NULL
blot	NULL
sheets	NULL
(	NULL
Clear	NULL
Blot	NULL
P	NULL
membrane	NULL
,	NULL
Atto	NULL
Corp.	NULL
,	NULL
Tokyo	NULL
)	NULL
.	NULL

The	NULL
sheets	NULL
were	NULL
blocked	NULL
with	NULL
Block	NULL
Ace	NULL
(	NULL
Dainippon	NULL
Pharmaceutical	NULL
Corp.	NULL
,	NULL
Osaka	NULL
)	NULL
at	NULL
4°C	NULL
overnight	NULL
,	NULL
incubated	NULL
with	NULL
various	NULL
antibodies	NULL
diluted	NULL
with	NULL
PBS	NULL
containing	NULL
10	NULL
%	NULL
Block	NULL
Ace	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
45	NULL
min	NULL
,	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
containing	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
.	NULL

Bound	NULL
antibodies	NULL
were	NULL
visualized	NULL
by	NULL
a	NULL
modification	NULL
of	NULL
Manson	NULL
's	NULL
method	NULL
``	NULL
``	NULL
using	NULL
a	NULL
soluble	NULL
immuncocomplex	NULL
of	NULL
peroxidase	NULL
with	NULL
rabbit	NULL
anti-peroxidase	NULL
serum	NULL
(	NULL
PAP	NULL
,	NULL
Dako	NULL
,	NULL
Denmark	NULL
)	NULL
(	NULL
PAP	NULL
method	NULL
)	NULL
.	NULL

Radio-immunoprecipitation	NULL
-	NULL
Analysis	NULL
of	NULL
antigen	NULL
molecules	NULL
was	NULL
also	NULL
performed	NULL
by	NULL
radio-immunoprecipitation	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

''	NULL
Briefly	NULL
,	NULL
1X10°	NULL
cells	NULL
resus-pended	NULL
in	NULL
1	NULL
rol	NULL
of	NULL
RPMI	NULL
medium	NULL
without	NULL
cysteine	NULL
were	NULL
incubated	NULL
with	NULL
100	NULL
Ci	NULL
of	NULL
*S-cysteine	NULL
(	NULL
specific	NULL
activity	NULL
1250	NULL
Ci/mmol	NULL
,	NULL
Amersham	NULL
Japan	NULL
)	NULL
at	NULL
37°C	NULL
for	NULL
4	NULL
h	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
ice-cold	NULL
PBS	NULL
,	NULL
and	NULL
then	NULL
lysed	NULL
in	NULL
1	NULL
mi	NULL
of	NULL
the	NULL
low	NULL
salt	NULL
extraction	NULL
buffer	NULL
.	NULL

Aliquots	NULL
(	NULL
200	NULL
gl	NULL
)	NULL
Table	NULL
I.	NULL
HTLV-I	NULL
,	NULL
STLV-I	NULL
and	NULL
HTLV-II	NULL
Retrovirus	NULL
Bearing	NULL
T	NULL
Cell	NULL
Lines	NULL
Used	NULL
in	NULL
This	NULL
Study	NULL
Originated	NULL
IL-2	NULL
requirement	NULL
Cell	NULL
line	NULL
from	NULL
for	NULL
cell	NULL
growth	NULL
Reference	NULL
HTLV-I-bearing	NULL
human	NULL
cell	NULL
lines	NULL
MT-2	NULL
normal	NULL
human	NULL
-	NULL
26	NULL
HUT1O2	NULL
ATL	NULL
patient	NULL
-	NULL
3	NULL
F-Taj	NULL
ATL	NULL
patient	NULL
Taj	NULL
-	NULL
27	NULL
ILT-Taj	NULL
ATL	NULL
patient	NULL
Taj	NULL
+	NULL
27	NULL
F-Aki	NULL
ATL	NULL
patient	NULL
Aki	NULL
-	NULL
27	NULL
ILT-Aki	NULL
ATL	NULL
patientAki	NULL
+	NULL
27	NULL
ILT-Som	NULL
ATL	NULL
patient	NULL
Som	NULL
+	NULL
27	NULL
ILT-500	NULL
healthy	NULL
HTLV-I	NULL
carrier	NULL
500	NULL
+	NULL
27	NULL
ILT-625	NULL
healthy	NULL
HTLV-I	NULL
carrier	NULL
625	NULL
+	NULL
27	NULL
STLV-I-bearing	NULL
cell	NULL
lines	NULL
ChM114-1	NULL
Chimpanzee	NULL
(	NULL
Africa	NULL
)	NULL
+	NULL
23	NULL
GMO650	NULL
Green	NULL
monkey	NULL
(	NULL
Africa	NULL
)	NULL
+	NULL
23	NULL
FM34	NULL
Formosan	NULL
monkey	NULL
(	NULL
Asia	NULL
)	NULL
+	NULL
23	NULL
Kani	NULL
11-6	NULL
Cynomolgus	NULL
monkey	NULL
(	NULL
Asia	NULL
)	NULL
-	NULL
28	NULL
PiM-3	NULL
Pig-tailed	NULL
macaque	NULL
(	NULL
Asia	NULL
)	NULL
-	NULL
23	NULL
JM86	NULL
Japanese	NULL
monkey	NULL
{	NULL
Asia	NULL
)	NULL
-	NULL
23	NULL
BMS	NULL
Bonnet	NULL
monkey	NULL
(	NULL
Asia	NULL
)	NULL
+	NULL
23	NULL
RFfM26-1	NULL
Red	NULL
face	NULL
macaque	NULL
(	NULL
Asia	NULL
)	NULL
-	NULL
23	NULL
HTLY-II-bearing	NULL
cell	NULL
line	NULL
normal	NULL
human	NULL
-	NULL
29	NULL
of	NULL
cell	NULL
lysates	NULL
were	NULL
reacted	NULL
with	NULL
mAbs	NULL
(	NULL
100	NULL
gl	NULL
of	NULL
culture	NULL
supernatant	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
,	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
100	NULL
wl	NULL
of	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Protein	NULL
A-Sepharose	NULL
4B	NULL
(	NULL
Pharmacia	NULL
)	NULL
overnight	NULL
.	NULL

Then	NULL
the	NULL
Sepharose	NULL
was	NULL
washed	NULL
three	NULL
times	NULL
and	NULL
the	NULL
eluates	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
on	NULL
10	NULL
%	NULL
separation	NULL
gels	NULL
,	NULL
and	NULL
the	NULL
gels	NULL
were	NULL
subjected	NULL
to	NULL
fluorography	NULL
at	NULL
-70°C	NULL
.	NULL

RESULTS	NULL
We	NULL
previously	NULL
reported	NULL
a	NULL
mAb	NULL
,	NULL
Lt-4	NULL
,	NULL
specific	NULL
for	NULL
HTLV-I	NULL
frans-activator	NULL
,	NULL
tax	NULL
,	NULL
,	NULL
antigen	NULL
.	NULL
``	NULL

In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
further	NULL
characterized	NULL
the	NULL
reactivity	NULL
of	NULL
Lt-4	NULL
with	NULL
various	NULL
cell	NULL
lines	NULL
bearing	NULL
HTLV-I	NULL
,	NULL
various	NULL
strains	NULL
of	NULL
STLYV-I	NULL
and	NULL
HTLV-II	NULL
by	NULL
and	NULL
immunoblot	NULL
assays	NULL
.	NULL

For	NULL
immunoblotting	NULL
,	NULL
we	NULL
separated	NULL
cell	NULL
31	NULL
K-	NULL
w	NULL
``	NULL
nace	NULL
Lt-4	NULL
antibody	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
of	NULL
tax	NULL
;	NULL
antigen	NULL
molecules	NULL
in	NULL
various	NULL
HTLV-I-bearing	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

Proteins	NULL
in	NULL
cell	NULL
lysates	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
on	NULL
10	NULL
%	NULL
separation	NULL
gels	NULL
and	NULL
blotted	NULL
onto	NULL
blotting	NULL
sheets	NULL
.	NULL

The	NULL
sheets	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
Lt-4	NULL
mAbs	NULL
bound	NULL
to	NULL
the	NULL
sheets	NULL
were	NULL
visualized	NULL
by	NULL
using	NULL
the	NULL
PAP	NULL
method	NULL
.	NULL

Heterogeneity	NULL
of	NULL
tax	NULL
Antigen	NULL
Molecules	NULL
lysate	NULL
proteins	NULL
by	NULL
SDS-PAGE	NULL
on	NULL
10	NULL
%	NULL
separation	NULL
gel	NULL
,	NULL
instead	NULL
of	NULL
12.5	NULL
%	NULL
gel	NULL
which	NULL
was	NULL
used	NULL
in	NULL
the	NULL
previous	NULL
experiments	NULL
,	NULL
to	NULL
facilitate	NULL
comparison	NULL
of	NULL
the	NULL
apparent	NULL
molecular	NULL
weights	NULL
of	NULL
tax	NULL
,	NULL
antigen	NULL
and	NULL
related	NULL
antigen	NULL
molecules	NULL
migrating	NULL
to	NULL
around	NULL
the	NULL
40	NULL
kd	NULL
position	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
shows	NULL
that	NULL
T	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
ATL	NULL
patients	NULL
and	NULL
HTLV-I	NULL
healthy	NULL
carriers	NULL
,	NULL
irrespective	NULL
of	NULL
IL-2	NULL
requirement	NULL
for	NULL
cell	NULL
growth	NULL
,	NULL
expressed	NULL
40	NULL
kd	NULL
antigen	NULL
molecules	NULL
detected	NULL
by	NULL
Lt-4	NULL
,	NULL
except	NULL
for	NULL
the	NULL
HUT1O2	NULL
cell	NULL
line	NULL
maintained	NULL
in	NULL
our	NULL
laboratory	NULL
which	NULL
expressed	NULL
39	NULL
kd	NULL
antigen	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Fig	NULL
.	NULL

1	NULL
seems	NULL
to	NULL
indicate	NULL
that	NULL
there	NULL
is	NULL
also	NULL
microheterogeneity	NULL
of	NULL
size	NULL
of	NULL
tax	NULL
;	NULL
antigen	NULL
molecules	NULL
expressed	NULL
in	NULL
the	NULL
other	NULL
HTLV-I-bearing	NULL
cell	NULL
lines	NULL
.	NULL

That	NULL
our	NULL
HUTIO2	NULL
expressed	NULL
aberrant	NULL
tax	NULL
,	NULL
;	NULL
antigen	NULL
was	NULL
confirmed	NULL
by	NULL
an	NULL
immunoprecipitation	NULL
experiment	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

From	NULL
*S-cysteine-labeled	NULL
lysates	NULL
of	NULL
our	NULL
HUT1O2	NULL
cells	NULL
,	NULL
Lt-4	NULL
precipitated	NULL
39	NULL
kd	NULL
protein	NULL
predominantly	NULL
in	NULL
addition	NULL
to	NULL
38	NULL
kd	NULL
protein	NULL
,	NULL
while	NULL
from	NULL
MT-2	NULL
and	NULL
F-Taj	NULL
cells	NULL
,	NULL
Lt-4	NULL
specifically	NULL
precipitated	NULL
40	NULL
kd	NULL
proteins	NULL
.	NULL

These	NULL
results	NULL
NOR	NULL
1	NULL
ant	NULL
bod	NULL
L	NULL
’	NULL
t-4	NULL
antlbody	NULL
(	NULL
anti-HTLV-1	NULL
gag	NULL
p32	NULL
»	NULL
)	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
tax	NULL
;	NULL
antigen	NULL
molecules	NULL
from	NULL
HTLV-I-bearing	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

Lysates	NULL
of	NULL
*S-Cys-labeled	NULL
cells	NULL
were	NULL
reacted	NULL
with	NULL
Lt-4	NULL
and	NULL
NOR-1	NULL
mAb	NULL
anti-HTLV-I	NULL
gag	NULL
p24	NULL
.	NULL

Immune	NULL
complex	NULL
was	NULL
precipitated	NULL
by	NULL
using	NULL
Protein	NULL
A-Sepharose	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
on	NULL
10	NULL
%	NULL
gel	NULL
.	NULL

227	NULL
Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

81	NULL
,	NULL
March	NULL
1990	NULL
A	NULL
MS	NULL
tvo	NULL
<	NULL
as	NULL
NS	NULL
,	NULL
S	NULL
2.8	NULL
u	NULL
ee	NULL
``	NULL
.~	NULL
B	NULL
&	NULL
-	NULL
&	NULL
aPC	NULL
dD	NULL
EC	NULL
&	NULL
.	NULL

h	NULL
EFCSSE	NULL
-	NULL
SPFSSS®	NULL
S	NULL
Lt-4	NULL
antibody	NULL
Fig	NULL
.	NULL

3.	NULL
indicated	NULL
that	NULL
most	NULL
HTLV-I-bearing	NULL
cell	NULL
tines	NULL
expressed	NULL
40	NULL
kd	NULL
tax	NULL
;	NULL
antigen	NULL
,	NULL
except	NULL
our	NULL
HUT1IO2	NULL
cell	NULL
line	NULL
which	NULL
expressed	NULL
39	NULL
kd	NULL
tax	NULL
;	NULL
antigen	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
tax	NULL
;	NULL
-related	NULL
antigens	NULL
recognized	NULL
by	NULL
Lt-4	NULL
are	NULL
expressed	NULL
in	NULL
cell	NULL
lines	NULL
bearing	NULL
HTLV-I-related	NULL
viruses	NULL
,	NULL
STLV-I	NULL
and	NULL
HTLV-II	NULL
,	NULL
we	NULL
screened	NULL
a	NULL
variety	NULL
of	NULL
simian	NULL
T	NULL
cell	NULL
lines	NULL
established	NULL
from	NULL
simians	NULL
naturally	NULL
infected	NULL
with	NULL
various	NULL
strains	NULL
of	NULL
STLY-I	NULL
,	NULL
and	NULL
a	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
bearing	NULL
HTLV-II	NULL
,	NULL
Ton-l.	NULL
An	NULL
immunofluorescence	NULL
assay	NULL
showed	NULL
that	NULL
while	NULL
all	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
tested	NULL
were	NULL
stained	NULL
by	NULL
mAbs	NULL
against	NULL
HTLV-I	NULL
gag	NULL
antigens	NULL
(	NULL
p19	NULL
,	NULL
p24	NULL
and/or	NULL
p15	NULL
)	NULL
and	NULL
HTLV-I	NULL
env	NULL
gp21	NULL
antigen	NULL
,	NULL
only	NULL
four	NULL
STLV-I-bearing	NULL
cell	NULL
lines	NULL
,	NULL
ChM114-1	NULL
,	NULL
GMO0650	NULL
,	NULL
Kanil1l-6	NULL
and	NULL
PtM-3	NULL
,	NULL
were	NULL
stained	NULL
by	NULL
Lt-4	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
further	NULL
the	NULL
Lt-4	NULL
reactivity	NULL
and	NULL
to	NULL
identify	NULL
Lt-4-reactive	NULL
antigen	NULL
molecules	NULL
,	NULL
immunoblot	NULL
assays	NULL
were	NULL
performed	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Lt-4	NULL
detected	NULL
antigens	NULL
with	NULL
apparent	NULL
molecular	NULL
weights	NULL
of	NULL
41	NULL
,	NULL
40	NULL
,	NULL
38	NULL
and	NULL
36	NULL
kd	NULL
in	NULL
the	NULL
cell	NULL
lysates	NULL
from	NULL
ChM114-1	NULL
,	NULL
GMO650	NULL
,	NULL
Kani	NULL
11-6	NULL
and	NULL
PtM3	NULL
cell	NULL
lines	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
FM34	NULL
cell	NULL
line	NULL
was	NULL
negative	NULL
for	NULL
Lt-4	NULL
staining	NULL
in	NULL
the	NULL
immunofluorescence	NULL
assay	NULL
,	NULL
but	NULL
the	NULL
immunoblot	NULL
assay	NULL
revealed	NULL
low	NULL
levels	NULL
of	NULL
228	NULL
(	NULL
Lt-4	NULL
antibody	NULL
Immunoblot	NULL
analysis	NULL
of	NULL
reactivity	NULL
of	NULL
Lt-4	NULL
with	NULL
T	NULL
cell	NULL
lines	NULL
bearing	NULL
various	NULL
strains	NULL
of	NULL
STLY-I	NULL
and	NULL
HTLY-II	NULL
.	NULL

Proteins	NULL
in	NULL
the	NULL
cell	NULL
lysates	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
blotted	NULL
onto	NULL
blotting	NULL
sheets	NULL
,	NULL
and	NULL
reacted	NULL
with	NULL
Lt-4	NULL
or	NULL
NOR-1	NULL
.	NULL

tm	NULL
=	NULL
#	NULL
:	NULL
-NOR-1	NULL
antibody	NULL
{	NULL
anti-HTLV-I	NULL
gag	NULL
p24	NULL
)	NULL
the	NULL
Lt-4-reactive	NULL
36	NULL
kd	NULL
antigen	NULL
,	NULL
However	NULL
,	NULL
even	NULL
in	NULL
the	NULL
immunoblot	NULL
assays	NULL
,	NULL
no	NULL
specific	NULL
antigen	NULL
was	NULL
detected	NULL
by	NULL
Lt-4	NULL
in	NULL
the	NULL
cell	NULL
lysates	NULL
from	NULL
BMS	NULL
,	NULL
JM86	NULL
,	NULL
RfM26-1	NULL
or	NULL
Ton-1	NULL
cell	NULL
line	NULL
.	NULL

There	NULL
was	NULL
no	NULL
apparent	NULL
difference	NULL
in	NULL
the	NULL
molecular	NULL
weight	NULL
of	NULL
the	NULL
mature	NULL
core	NULL
antigen	NULL
,	NULL
p34	NULL
,	NULL
expressed	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
lines	NULL
tested	NULL
.	NULL

The	NULL
data	NULL
of	NULL
Fig	NULL
.	NULL

3	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
IIL	NULL
.	NULL

DISCUSSION	NULL
The	NULL
present	NULL
study	NULL
showed	NULL
that	NULL
:	NULL
(	NULL
1	NULL
)	NULL
mAb	NULL
Lt-4	NULL
directed	NULL
against	NULL
the	NULL
tax	NULL
,	NULL
antigen	NULL
detected	NULL
40	NULL
kd	NULL
antigen	NULL
molecules	NULL
in	NULL
most	NULL
HTLYV-I-bearing	NULL
cell	NULL
lines	NULL
except	NULL
our	NULL
HUT-102	NULL
cell	NULL
line	NULL
;	NULL
(	NULL
2	NULL
)	NULL
Lt-4	NULL
also	NULL
reacted	NULL
with	NULL
some	NULL
but	NULL
not	NULL
all	NULL
STLV-I-bearing	NULL
T	NULL
cell	NULL
lines	NULL
established	NULL
from	NULL
monkeys	NULL
naturally	NULL
infected	NULL
with	NULL
various	NULL
strains	NULL
of	NULL
STLY-I	NULL
;	NULL
(	NULL
3	NULL
)	NULL
Lt-4	NULL
reactive	NULL
antigens	NULL
in	NULL
the	NULL
STLV-I	NULL
bearing	NULL
cells	NULL
were	NULL
hetrogeneous	NULL
in	NULL
molecular	NULL
weight	NULL
;	NULL
and	NULL
(	NULL
4	NULL
)	NULL
Lt-4	NULL
did	NULL
not	NULL
react	NULL
with	NULL
the	NULL
HTLV-I	NULL
tax	NULL
(	NULL
tax	NULL
;	NULL
)	NULL
antigen	NULL
.	NULL

The	NULL
reasons	NULL
why	NULL
our	NULL
HUT1O2	NULL
cell	NULL
line	NULL
synthesized	NULL
39	NULL
kd	NULL
tax	NULL
,	NULL
antigen	NULL
molecules	NULL
are	NULL
not	NULL
known	NULL
.	NULL

This	NULL
is	NULL
not	NULL
unique	NULL
to	NULL
our	NULL
HUT1O2	NULL
cell	NULL
line	NULL
since	NULL
an	NULL
HUT1O2	NULL
cell	NULL
line	NULL
Table	NULL
II	NULL
.	NULL

Immunofiuorescence	NULL
Analysis	NULL
of	NULL
the	NULL
Expression	NULL
of	NULL
Lt-4-reactive	NULL
Antigens	NULL
in	NULL
STLY-I-	NULL
and	NULL
HTLY-II-bearing	NULL
T	NULL
Cell	NULL
Lines	NULL
Reactivity	NULL
with	NULL
mAb	NULL
Lt-4	NULL
GIN-14	NULL
NOR-l	NULL
FR-45	NULL
TA-2l	NULL
H-31	NULL
anti-	NULL
-	NULL
anti-	NULL
-	NULL
anti	NULL
-	NULL
anti-	NULL
-	NULL
anti-	NULL
_	NULL
anti	NULL
tax	NULL
,	NULL
-	NULL
Opl9	NULL
0	NULL
p24	NULL
0	NULL
plo	NULL
ILR	NULL
HTLY-I-bearing	NULL
cell	NULL
lines	NULL
MT-2	NULL
4+	NULL
04400	NULL
4+	NULL
440	NULL
o4+	NULL
HUTIOZ	NULL
|	NULL
44	NULL
0	NULL
4400	NULL
4400	NULL
44+	NULL
44	NULL
4+	NULL
STLY-I-bearing	NULL
cell	NULL
lines	NULL
Cell	NULL
line	NULL
ChMII4-1	NULL
|	NULL
400	NULL
+400	NULL
44+	NULL
0	NULL
0	NULL
4+0	NULL
44+	NULL
4+	NULL
GMO0650	NULL
fm	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Kani	NULL
11-6	NULL
_	NULL
+-	NULL
4+	NULL
++	NULL
-	NULL
+	NULL
+	NULL
PiM-3	NULL
+o	NULL
-t4	NULL
-+	NULL
+	NULL
+	NULL
+	NULL
FM34	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+o	NULL
4+	NULL
JM86	NULL
-o	NULL
p	NULL
o	NULL
ofR	NULL
o	NULL
Boot	NULL
oo	NULL
BMS	NULL
~	NULL
o	NULL
4+	NULL
+	NULL
+	NULL
+	NULL
RfM261	NULL
_	NULL
=	NULL
0	NULL
+o	NULL
44	NULL
o	NULL
to	NULL
44	NULL
0	NULL
4	NULL
HTLY-I-bearing	NULL
cell	NULL
line	NULL
Ton-1	NULL
-	NULL
0	NULL
44	NULL
0	NULL
44	NULL
0	NULL
oo++	NULL
a	NULL
)	NULL
Fixed	NULL
cells	NULL
were	NULL
examined	NULL
by	NULL
an	NULL
indirect	NULL
immunofluorescence	NULL
method	NULL
.	NULL

b	NULL
)	NULL
Reactivities	NULL
of	NULL
mAbs	NULL
were	NULL
expressed	NULL
as	NULL
:	NULL
-	NULL
,	NULL
negative	NULL
;	NULL
*	NULL
,	NULL
weakly	NULL
positive	NULL
;	NULL
+	NULL
,	NULL
positive	NULL
;	NULL
and	NULL
++	NULL
,	NULL
strongly	NULL
positive	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
flnorescence	NULL
microscopy	NULL
.	NULL

maintained	NULL
in	NULL
another	NULL
laboratory	NULL
also	NULL
synthesized	NULL
a	NULL
similar	NULL
39	NULL
kd	NULL
tax	NULL
,	NULL
antigen	NULL
(	NULL
Drs	NULL
.	NULL

Nyunoya	NULL
and	NULL
Shimotohno	NULL
,	NULL
personal	NULL
communication	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
there	NULL
is	NULL
either	NULL
a	NULL
deletion	NULL
of	NULL
amino	NULL
acids	NULL
or	NULL
an	NULL
aberrant	NULL
post-translational	NULL
modification	NULL
of	NULL
the	NULL
tax	NULL
;	NULL
antigen	NULL
molecule	NULL
in	NULL
the	NULL
HUT	NULL
102	NULL
cell	NULL
lines	NULL
.	NULL

Sodroski	NULL
et	NULL
al	NULL
.	NULL
``	NULL

observed	NULL
a	NULL
heterogeneity	NULL
of	NULL
the	NULL
tax	NULL
;	NULL
antigens	NULL
in	NULL
some	NULL
HTLY-I-immor-talized	NULL
human	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
they	NULL
speculated	NULL
that	NULL
there	NULL
might	NULL
be	NULL
a	NULL
variation	NULL
in	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
the	NULL
tax	NULL
,	NULL
or	NULL
post-transcriptional	NULL
modifications	NULL
of	NULL
the	NULL
tax	NULL
,	NULL
antigen	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
was	NULL
reported	NULL
that	NULL
the	NULL
tax	NULL
;	NULL
antigen	NULL
was	NULL
phosphorylated	NULL
when	NULL
the	NULL
antigen	NULL
was	NULL
produced	NULL
with	NULL
a	NULL
baculovirus	NULL
vector	NULL
in	NULL
lymphoid	NULL
cells	NULL
``	NULL
``	NULL
and	NULL
insect	NULL
cells	NULL
.	NULL
``	NULL

The	NULL
Lt-4-reactive	NULL
tax	NULL
;	NULL
-related	NULL
antigens	NULL
expressed	NULL
in	NULL
STLYV-I	NULL
bearing	NULL
cells	NULL
may	NULL
be	NULL
identical	NULL
or	NULL
related	NULL
to	NULL
transactivator	NULL
antigens	NULL
encoded	NULL
by	NULL
STLY-I	NULL
pX	NULL
gene	NULL
.	NULL

If	NULL
this	NULL
is	NULL
the	NULL
case	NULL
,	NULL
since	NULL
each	NULL
of	NULL
the	NULL
STLYV-I	NULL
strains	NULL
was	NULL
suggested	NULL
to	NULL
have	NULL
diverged	NULL
separately	NULL
after	NULL
divergence	NULL
from	NULL
there	NULL
may	NULL
have	NULL
been	NULL
alteration	NULL
in	NULL
the	NULL
trans-activator	NULL
gene	NULL
of	NULL
each	NULL
STLV-I	NULL
strain	NULL
during	NULL
evolu-tion	NULL
,	NULL
which	NULL
may	NULL
explain	NULL
both	NULL
the	NULL
different	NULL
reactivity	NULL
of	NULL
Lt-4	NULL
with	NULL
the	NULL
panel	NULL
of	NULL
STLV-I-bearing	NULL
cell	NULL
lines	NULL
and	NULL
the	NULL
heterogeneity	NULL
in	NULL
molecular	NULL
weight	NULL
of	NULL
the	NULL
Lt-4-reactive	NULL
antigens	NULL
among	NULL
STLV-I-bearing	NULL
cell	NULL
lines	NULL
.	NULL

It	NULL
has	NULL
been	NULL
Heterogeneity	NULL
of	NULL
tax	NULL
Antigen	NULL
Molecules	NULL
Table	NULL
III	NULL
.	NULL

Summarized	NULL
Data	NULL
on	NULL
the	NULL
Reactivity	NULL
of	NULL
Lt-4	NULL
with	NULL
Various	NULL
T	NULL
Cell	NULL
Lines	NULL
Bearing	NULL
HTLV-I	NULL
,	NULL
STLY-I	NULL
and	NULL
HTLV-I	NULL
Antigen	NULL
detected	NULL
by	NULL
Lt-4	NULL
Cell	NULL
line	NULL
(	NULL
kd	NULL
)	NULL
HTLY-I-bearing	NULL
cell	NULL
lines	NULL
MT-2	NULL
68	NULL
,	NULL
40	NULL
HUT1O2	NULL
39	NULL
F-Taj	NULL
40	NULL
ILT-Taj	NULL
40	NULL
F-Aki	NULL
40	NULL
ILT-Aki	NULL
40	NULL
ILT-Som	NULL
40	NULL
ILT-300	NULL
40	NULL
ILT-625	NULL
40	NULL
STLYV-I-bearing	NULL
cell	NULL
lines	NULL
ChM114-1	NULL
41	NULL
GMO650	NULL
40	NULL
Kani	NULL
11-6	NULL
38	NULL
PIM-3	NULL
36	NULL
FM34	NULL
36	NULL
FPMB86	NULL
none	NULL
BMS	NULL
none	NULL
RFM26-1	NULL
none	NULL
HTLY-II-bearing	NULL
cell	NULL
line	NULL
Ton-1	NULL
none	NULL
shown	NULL
that	NULL
HTLV-I	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
African	NULL
but	NULL
not	NULL
the	NULL
Asian	NULL
subtype	NULL
of	NULL
STLY-I	NULL
based	NULL
on	NULL
the	NULL
homology	NULL
of	NULL
nucleotide	NULL
sequences	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL
``	NULL

''	NULL
That	NULL
Lt-4	NULL
reacted	NULL
with	NULL
2	NULL
out	NULL
of	NULL
2	NULL
cell	NULL
lines	NULL
bearing	NULL
the	NULL
African	NULL
subtype	NULL
STLV-I	NULL
strains	NULL
,	NULL
but	NULL
only	NULL
3	NULL
out	NULL
of	NULL
6	NULL
cell	NULL
lines	NULL
bearing	NULL
the	NULL
Asian	NULL
subtype	NULL
STLY-I	NULL
strains	NULL
,	NULL
may	NULL
suggest	NULL
that	NULL
the	NULL
Lt-4-reactive	NULL
antigenic	NULL
epitope	NULL
is	NULL
conserved	NULL
better	NULL
in	NULL
the	NULL
African	NULL
subtype	NULL
STLY-I	NULL
strains	NULL
thar	NULL
in	NULL
the	NULL
Asian	NULL
subtype	NULL
STLY-I	NULL
strains	NULL
.	NULL

The	NULL
present	NULL
study	NULL
also	NULL
showed	NULL
that	NULL
Lt-4	NULL
had	NULL
a	NULL
different	NULL
specificity	NULL
from	NULL
other	NULL
monospecific	NULL
antisera	NULL
prepared	NULL
against	NULL
various	NULL
tax	NULL
,	NULL
peptides	NULL
or	NULL
a	NULL
fused	NULL
protein	NULL
:	NULL
(	NULL
1	NULL
)	NULL
antisera	NULL
against	NULL
tax	NULL
,	NULL
peptides	NULL
,	NULL
OP-1	NULL
and	NULL
OP-4	NULL
corresponding	NULL
to	NULL
N-	NULL
and	NULL
C-terminal	NULL
regions	NULL
of	NULL
both	NULL
the	NULL
tax	NULL
;	NULL
and	NULL
tax	NULL
;	NULL
antigens	NULL
,	NULL
respectively	NULL
,	NULL
reacted	NULL
both	NULL
with	NULL
tax	NULL
,	NULL
and	NULL
tax	NULL
;	NULL
antigens	NULL
``	NULL
'	NULL
``	NULL
;	NULL
and	NULL
(	NULL
2	NULL
)	NULL
antiserum	NULL
against	NULL
bGH-p407	NULL
,	NULL
that	NULL
covers	NULL
54	NULL
amino	NULL
acids	NULL
located	NULL
at	NULL
the	NULL
C-terminus	NULL
of	NULL
the	NULL
tax	NULL
,	NULL
antigen	NULL
,	NULL
reacted	NULL
with	NULL
the	NULL
tax	NULL
;	NULL
but	NULL
not	NULL
with	NULL
tax	NULL
;	NULL
antigen	NULL
.	NULL
``	NULL

However	NULL
,	NULL
this	NULL
antiserum	NULL
also	NULL
reacted	NULL
with	NULL
the	NULL
BMS	NULL
cell	NULL
line	NULL
,	NULL
``	NULL
``	NULL
with	NULL
which	NULL
Lt-4	NULL
did	NULL
not	NULL
react	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
tax	NULL
,	NULL
antigen	NULL
contains	NULL
at	NULL
least	NULL
four	NULL
antigenic	NULL
determinants	NULL
recognized	NULL
by	NULL
antibodies	NULL
.	NULL

Further	NULL
biochemical	NULL
analysis	NULL
of	NULL
tax	NULL
;	NULL
antigen	NULL
and	NULL
related	NULL
antigens	NULL
by	NULL
two-dimensional	NULL
gel	NULL
electrophoresis	NULL
and	NULL
partial	NULL
proteolytic	NULL
mapping	NULL
,	NULL
and	NULL
a	NULL
study	NULL
of	NULL
the	NULL
anti	NULL
229	NULL
Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

81	NULL
,	NULL
March	NULL
1990	NULL
genicity	NULL
of	NULL
these	NULL
antigens	NULL
with	NULL
a	NULL
library	NULL
of	NULL
mAbs	NULL
specific	NULL
for	NULL
various	NULL
epitopes	NULL
of	NULL
the	NULL
tax	NULL
;	NULL
antigen	NULL
are	NULL
required	NULL
to	NULL
elucidate	NULL
the	NULL
tax	NULL
,	NULL
antigenic	NULL
structure	NULL
and	NULL
its	NULL
relationship	NULL
to	NULL
tax	NULL
antigens	NULL
encoded	NULL
by	NULL
other	NULL
HTLV-I-related	NULL
viruses	NULL
.	NULL

Such	NULL
studies	NULL
are	NULL
in	NULL
progress	NULL
.	NULL

REFERENCES	NULL
1	NULL
)	NULL
Hinuma	NULL
,	NULL
Y.	NULL
,	NULL
Nagata	NULL
,	NULL
K.	NULL
,	NULL
Hanaoka	NULL
,	NULL
M.	NULL
,	NULL
Nakai	NULL
,	NULL
M.	NULL
,	NULL
Matsumoto	NULL
,	NULL
T.	NULL
,	NULL
Kinoshita	NULL
,	NULL
K.	NULL
,	NULL
Shirakawa	NULL
,	NULL
S.	NULL
and	NULL
Miyoshi	NULL
,	NULL
I	NULL
.	NULL

Adult	NULL
T-cell	NULL
leukemia	NULL
:	NULL
antigen	NULL
in	NULL
an	NULL
ATL	NULL
cell	NULL
line	NULL
and	NULL
detection	NULL
of	NULL
antibodies	NULL
to	NULL
the	NULL
antigen	NULL
in	NULL
human	NULL
sera	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
,	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
78	NULL
,	NULL
6476-6480	NULL
(	NULL
1981	NULL
)	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Miyoshi	NULL
,	NULL
I.	NULL
and	NULL
Hinuma	NULL
,	NULL
Y	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
retrovirus	NULL
from	NULL
cell	NULL
lines	NULL
of	NULL
human	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
and	NULL
its	NULL
implication	NULL
in	NULL
the	NULL
disease	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
79	NULL
,	NULL
2031-2035	NULL
(	NULL
1982	NULL
)	NULL
.	NULL

3	NULL
}	NULL
Poiesz	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Ruscetti	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Gazdar	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Bunn	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Minna	NULL
,	NULL
J.	NULL
D.	NULL
and	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
Detection	NULL
and	NULL
isolation	NULL
of	NULL
type	NULL
C	NULL
retrovirus	NULL
particles	NULL
from	NULL
fresh	NULL
and	NULL
cultured	NULL
lymphocytes	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
cutaneous	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
.	NULL

Nati	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
77	NULL
,	NULL
7415-7419	NULL
(	NULL
1980	NULL
)	NULL
.	NULL

4	NULL
)	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Kalyanaraman	NULL
,	NULL
V.	NULL
S.	NULL
,	NULL
Sarngadharan	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Sliski	NULL
,	NULL
A.	NULL
,	NULL
Yonderheid	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Maeda	NULL
,	NULL
M.	NULL
,	NULL
Nakao	NULL
,	NULL
Y.	NULL
,	NULL
Yamada	NULL
,	NULL
K.	NULL
,	NULL
Ito	NULL
,	NULL
Y.	NULL
,	NULL
Gutensohn	NULL
,	NULL
N.	NULL
,	NULL
Murphy	NULL
,	NULL
S.	NULL
,	NULL
Bunn	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Jr.	NULL
,	NULL
Catovsky	NULL
,	NULL
D.	NULL
,	NULL
Greaves	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Blayney	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Blattner	NULL
,	NULL
W.	NULL
,	NULL
Jarrett	NULL
,	NULL
W.	NULL
F.	NULL
H.	NULL
,	NULL
zur	NULL
Hausen	NULL
,	NULL
H.	NULL
,	NULL
Seligmann	NULL
,	NULL
M.	NULL
,	NULL
Brouet	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Haynes	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
Jegasothy	NULL
,	NULL
B.	NULL
V.	NULL
,	NULL
Jaffe	NULL
,	NULL
E.	NULL
,	NULL
Cossman	NULL
,	NULL
J.	NULL
and	NULL
Robert-Guroff	NULL
,	NULL
M.	NULL
Association	NULL
of	NULL
the	NULL
human	NULL
type-C	NULL
retrovirus	NULL
with	NULL
a	NULL
subset	NULL
of	NULL
adult	NULL
T-cell	NULL
cancer	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
43	NULL
,	NULL
3892-3899	NULL
(	NULL
1983	NULL
)	NULL
.	NULL

5	NULL
)	NULL
Yoshida	NULL
,	NULL
M.	NULL
and	NULL
Seiki	NULL
,	NULL
M.	NULL
Recent	NULL
advances	NULL
in	NULL
the	NULL
molecular	NULL
biology	NULL
of	NULL
HTLY-I	NULL
:	NULL
trans-activation	NULL
of	NULL
viral	NULL
and	NULL
cellular	NULL
genes	NULL
.	NULL

Anx	NULL
,	NULL
Rey	NULL
,	NULL
Immunol	NULL
.	NULL

,	NULL
5	NULL
,	NULL
541-549	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

6	NULL
)	NULL
Lee	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
Coligan	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Sodroski	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Haseltine	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
Salahuddin	NULL
,	NULL
S.	NULL
Z.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
and	NULL
Essex	NULL
,	NULL
M.	NULL
Antigens	NULL
encoded	NULL
by	NULL
the	NULL
3'-terminal	NULL
region	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
;	NULL
evidence	NULL
for	NULL
a	NULL
functional	NULL
gene	NULL
.	NULL

Science	NULL
,	NULL
226	NULL
,	NULL
57-61	NULL
(	NULL
1984	NULL
)	NULL
.	NULL

7	NULL
)	NULL
Salmon	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Cline	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Golde	NULL
,	NULL
D.	NULL
W.	NULL
and	NULL
Chen	NULL
,	NULL
I.	NULL
S.	NULL
Y	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
putative	NULL
transforming	NULL
protein	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
viruses	NULL
HTLY-I	NULL
and	NULL
HTLV-II	NULL
.	NULL

Science	NULL
,	NULL
226	NULL
,	NULL
61-65	NULL
(	NULL
1984	NULL
)	NULL
.	NULL

8	NULL
)	NULL
Salmon	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Shimotohno	NULL
,	NULL
K.	NULL
,	NULL
Press	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Souza	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Murdock	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Cline	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Golde	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Gasson	NULL
,	NULL
J.	NULL
C.	NULL
and	NULL
Chen	NULL
,	NULL
L	NULL
S.	NULL
Y	NULL
.	NULL

Studies	NULL
of	NULL
the	NULL
putative	NULL
transforming	NULL
protein	NULL
of	NULL
the	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
.	NULL

Science	NULL
,	NULL
227	NULL
,	NULL
1427-1430	NULL
(	NULL
1985	NULL
)	NULL
.	NULL

9	NULL
)	NULL
Sodroski	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Goh	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Salahuddin	NULL
,	NULL
S.	NULL
Z.	NULL
,	NULL
Aldovini	NULL
,	NULL
A.	NULL
,	NULL
Franchini	NULL
,	NULL
G.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Sugamura	NULL
,	NULL
K.	NULL
,	NULL
Hinuma	NULL
,	NULL
Y.	NULL
and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A.	NULL
trans	NULL
Activation	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
correlates	NULL
with	NULL
expression	NULL
of	NULL
the	NULL
x-lor	NULL
protein	NULL
.	NULL

J	NULL
.	NULL

Firol	NULL
.	NULL

,	NULL
55	NULL
,	NULL
§31-8	NULL
%	NULL
35	NULL
(	NULL
1985	NULL
)	NULL
.	NULL

2	NULL
w	NULL
230	NULL
ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Dr.	NULL
S.	NULL
R.	NULL
Jennings	NULL
for	NULL
reading	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
Grant-in-Aid	NULL
for	NULL
Cancer	NULL
Research	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Health	NULL
and	NULL
Welfare	NULL
,	NULL
Japan	NULL
.	NULL

(	NULL
Received	NULL
October	NULL
18	NULL
,	NULL
1989/Accepted	NULL
January	NULL
23	NULL
,	NULL
1990	NULL
)	NULL
10	NULL
)	NULL
Shimotohno	NULL
,	NULL
K.	NULL
,	NULL
Miwa	NULL
,	NULL
M.	NULL
,	NULL
Salmon	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Chen	NULL
,	NULL
1	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
Hoshino	NULL
,	NULL
H.	NULL
,	NULL
Takano	NULL
,	NULL
M.	NULL
,	NULL
Fujino	NULL
,	NULL
M.	NULL
and	NULL
Sugimura	NULL
,	NULL
T.	NULL
Identification	NULL
of	NULL
new	NULL
gene	NULL
products	NULL
coded	NULL
from	NULL
X	NULL
regions	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
viruses	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
82	NULL
,	NULL
302-306	NULL
(	NULL
1985	NULL
)	NULL
.	NULL

11	NULL
)	NULL
Sickevitz	NULL
,	NULL
M.	NULL
,	NULL
Feinberg	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Hobrook	NULL
,	NULL
N.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
and	NULL
Green	NULL
,	NULL
W.	NULL
C.	NULL
Activation	NULL
of	NULL
interleukin	NULL
2	NULL
and	NULL
interleukin	NULL
2	NULL
receptor	NULL
(	NULL
Tac	NULL
)	NULL
promoter	NULL
expression	NULL
by	NULL
the	NULL
transactivator	NULL
(	NULL
tat	NULL
)	NULL
gene	NULL
product	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
,	NULL
type-I	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
,	NULL
Sci	NULL
.	NULL

USA	NULL
,	NULL
84	NULL
,	NULL
5389-5393	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

12	NULL
)	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Shibuya	NULL
,	NULL
H.	NULL
,	NULL
Harada	NULL
,	NULL
H.	NULL
,	NULL
Hatakeyama	NULL
,	NULL
M.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Inoue	NULL
,	NULL
J.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
Evidence	NULL
for	NULL
aberrant	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
autocrine	NULL
loop	NULL
by	NULL
HTLY-L-encoded	NULL
p40	NULL
``	NULL
and	NULL
T3/Ti	NULL
complex	NULL
triggering	NULL
.	NULL

Cell	NULL
,	NULL
48	NULL
,	NULL
343-350	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

13	NULL
)	NULL
Yamamoto	NULL
,	NULL
N.	NULL
,	NULL
Schneider	NULL
,	NULL
J.	NULL
,	NULL
Koyanagi	NULL
,	NULL
Y.	NULL
,	NULL
Hinuma	NULL
,	NULL
Y.	NULL
and	NULL
Hunsmann	NULL
,	NULL
G.	NULL
Adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
ATL	NULL
)	NULL
virus-specific	NULL
antibodies	NULL
in	NULL
ATL	NULL
patients	NULL
and	NULL
healthy	NULL
virus	NULL
car-riers	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
32	NULL
,	NULL
281-287	NULL
(	NULL
1983	NULL
)	NULL
.	NULL

14	NULL
)	NULL
Schiipbach	NULL
,	NULL
J.	NULL
,	NULL
Kalyanaraman	NULL
,	NULL
¥	NULL
.	NULL

S.	NULL
,	NULL
Sarngadharan	NULL
,	NULL
M	NULL
.	NULL

CF	NULL
.	NULL

,	NULL
Nakao	NULL
,	NULL
Y.	NULL
,	NULL
Ito	NULL
,	NULL
Y.	NULL
and	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
Antibodies	NULL
against	NULL
three	NULL
purified	NULL
structural	NULL
proteins	NULL
of	NULL
the	NULL
human	NULL
type-C	NULL
retrovirus	NULL
,	NULL
HTLV	NULL
,	NULL
in	NULL
Japanese	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
pa-tients	NULL
,	NULL
healthy	NULL
family	NULL
members	NULL
,	NULL
and	NULL
unrelated	NULL
normals	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
32	NULL
,	NULL
583-590	NULL
(	NULL
1983	NULL
)	NULL
.	NULL

15	NULL
)	NULL
Schneider	NULL
,	NULL
J.	NULL
,	NULL
Yamamoto	NULL
,	NULL
N.	NULL
,	NULL
Hinuma	NULL
,	NULL
Y.	NULL
and	NULL
Hunsmann	NULL
,	NULL
G.	NULL
Sera	NULL
from	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
patient	NULL
react	NULL
with	NULL
envelope	NULL
and	NULL
core	NULL
polypeptides	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
.	NULL

Firology	NULL
,	NULL
132	NULL
,	NULL
1-11	NULL
(	NULL
1984	NULL
)	NULL
.	NULL

16	NULL
)	NULL
Kiyokawa	NULL
,	NULL
T.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Iwashita	NULL
,	NULL
S.	NULL
,	NULL
Imagawa	NULL
,	NULL
K.	NULL
,	NULL
Shimizu	NULL
,	NULL
F.	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
p27	NULL
``	NULL
``	NULL
``	NULL
and	NULL
p21*	NULL
``	NULL
``	NULL
,	NULL
proteins	NULL
encoded	NULL
by	NULL
the	NULL
pX	NULL
sequence	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Proc	NULL
,	NULL
Natl	NULL
Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
82	NULL
,	NULL
8359-8363	NULL
(	NULL
1985	NULL
)	NULL
.	NULL

17	NULL
)	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Hattori	NULL
,	NULL
S.	NULL
,	NULL
Hirayama	NULL
,	NULL
Y.	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
Human	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
:	NULL
complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
provirus	NULL
genome	NULL
integrated	NULL
in	NULL
leukemia	NULL
cell	NULL
DNA	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
80	NULL
,	NULL
3618-3622	NULL
(	NULL
1983	NULL
)	NULL
.	NULL

18	NULL
)	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Hikikoshi	NULL
,	NULL
A.	NULL
,	NULL
Taniguchi	NULL
,	NULL
T.	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
Expression	NULL
of	NULL
the	NULL
pX	NULL
gene	NULL
of	NULL
HTLV-I	NULL
:	NULL
general	NULL
splicing	NULL
mechanism	NULL
in	NULL
the	NULL
HTLV-I	NULL
family	NULL
.	NULL

Science	NULL
,	NULL
228	NULL
,	NULL
1532-1534	NULL
(	NULL
1985	NULL
)	NULL
.	NULL

19	NULL
)	NULL
Shimotohno	NULL
,	NULL
K.	NULL
,	NULL
Takano	NULL
,	NULL
M.	NULL
,	NULL
Miwa	NULL
,	NULL
M.	NULL
,	NULL
Hoshino	NULL
,	NULL
H.	NULL
,	NULL
Ito	NULL
,	NULL
H.	NULL
and	NULL
Sugimura	NULL
,	NULL
T.	NULL
Structure	NULL
of	NULL
the	NULL
pX	NULL
protein	NULL
deduced	NULL
20	NULL
}	NULL
21	NULL
)	NULL
22	NULL
)	NULL
23	NULL
)	NULL
24	NULL
)	NULL
25	NULL
)	NULL
26	NULL
)	NULL
27	NULL
)	NULL
28	NULL
)	NULL
from	NULL
the	NULL
nucleotide	NULL
sequence	NULL
of	NULL
a	NULL
cDNA	NULL
clone	NULL
of	NULL
pX	NULL
mRNA	NULL
in	NULL
cells	NULL
infected	NULL
with	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type-I	NULL
.	NULL

Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
76	NULL
,	NULL
241-244	NULL
(	NULL
1985	NULL
)	NULL
.	NULL

Tsujimoto	NULL
,	NULL
A	NULL
,	NULL
Tsujimoto	NULL
,	NULL
H.	NULL
,	NULL
Yanaihars	NULL
,	NULL
N.	NULL
,	NULL
Abe	NULL
,	NULL
K.	NULL
,	NULL
Hayami	NULL
,	NULL
M.	NULL
,	NULL
Miwa	NULL
,	NULL
M.	NULL
and	NULL
Shimotohno	NULL
,	NULL
K.	NULL
Detection	NULL
of	NULL
the	NULL
X	NULL
gene	NULL
product	NULL
of	NULL
simian	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

,	NULL
196	NULL
,	NULL
301-304	NULL
(	NULL
1986	NULL
)	NULL
.	NULL

Miyoshi	NULL
,	NULL
I.	NULL
,	NULL
Ohtsuki	NULL
,	NULL
Y.	NULL
,	NULL
Fujishita	NULL
,	NULL
M.	NULL
,	NULL
Yoshimoto	NULL
,	NULL
S.	NULL
,	NULL
Kubonishi	NULL
,	NULL
I.	NULL
and	NULL
Minezawa	NULL
,	NULL
M.	NULL
Detection	NULL
of	NULL
type	NULL
C	NULL
virus	NULL
particles	NULL
in	NULL
Japanese	NULL
monkeys	NULL
seropositive	NULL
to	NULL
adult	NULL
T-cell	NULL
leukemia-associated	NULL
antigens	NULL
.	NULL

Gann	NULL
,	NULL
73	NULL
,	NULL
§48-849	NULL
(	NULL
1982	NULL
)	NULL
.	NULL

Yamamoto	NULL
,	NULL
N.	NULL
,	NULL
Kobayashi	NULL
,	NULL
N.	NULL
,	NULL
Takeuchi	NULL
,	NULL
K.	NULL
,	NULL
Koyanagi	NULL
,	NULL
Y.	NULL
,	NULL
Hatanaka	NULL
,	NULL
M.	NULL
,	NULL
Hinuma	NULL
,	NULL
Y.	NULL
,	NULL
Chosa	NULL
,	NULL
T.	NULL
,	NULL
Schneider	NULL
,	NULL
J.	NULL
H.	NULL
and	NULL
Hunsmann	NULL
,	NULL
G.	NULL
Characterization	NULL
of	NULL
African	NULL
green	NULL
monkey	NULL
B-cell	NULL
lines	NULL
releasing	NULL
an	NULL
adult	NULL
T-cell	NULL
leukemia-virus-related	NULL
agent	NULL
.	NULL

Int	NULL
,	NULL
J	NULL
.	NULL

Cancer	NULL
,	NULL
34	NULL
,	NULL
77-82	NULL
(	NULL
1984	NULL
)	NULL
.	NULL

Tsujimoto	NULL
,	NULL
H.	NULL
,	NULL
Komuro	NULL
,	NULL
A.	NULL
,	NULL
Hifima	NULL
,	NULL
K.	NULL
,	NULL
Miyamoto	NULL
,	NULL
J.	NULL
,	NULL
Ishikawa	NULL
,	NULL
K.	NULL
and	NULL
Hayami	NULL
,	NULL
M.	NULL
Isolation	NULL
of	NULL
simian	NULL
retroviruses	NULL
closely	NULL
related	NULL
to	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
by	NULL
establishment	NULL
of	NULL
lymphoid	NULL
cell	NULL
lines	NULL
from	NULL
various	NULL
nonhuman	NULL
primates	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
35	NULL
,	NULL
377-384	NULL
(	NULL
1985	NULL
)	NULL
.	NULL

Watanabe	NULL
,	NULL
S.	NULL
,	NULL
Sato	NULL
,	NULL
Y.	NULL
,	NULL
Shima	NULL
,	NULL
H.	NULL
,	NULL
Shimotohno	NULL
,	NULL
K.	NULL
and	NULL
Miwa	NULL
,	NULL
M.	NULL
Monoclonal	NULL
antibody	NULL
NCC-pX-1G	NULL
reactive	NULL
with	NULL
gene	NULL
products	NULL
coded	NULL
from	NULL
X	NULL
regions	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
.	NULL

Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
77	NULL
,	NULL
338-341	NULL
(	NULL
1986	NULL
)	NULL
.	NULL

Lee	NULL
,	NULL
B.	NULL
,	NULL
Tanaka	NULL
,	NULL
Y.	NULL
and	NULL
Tozawa	NULL
,	NULL
H.	NULL
Monoclonal	NULL
antibody	NULL
defining	NULL
tax	NULL
;	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type-I	NULL
.	NULL

Tohoku	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
157	NULL
,	NULL
1-11	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

Miyoshi	NULL
,	NULL
L.	NULL
,	NULL
Kubonishi	NULL
,	NULL
I.	NULL
,	NULL
Yoshimoto	NULL
,	NULL
S.	NULL
and	NULL
Shiraishi	NULL
,	NULL
Y	NULL
.	NULL

A	NULL
T-cell	NULL
line	NULL
derived	NULL
from	NULL
normal	NULL
human	NULL
cord	NULL
leukocytes	NULL
by	NULL
co-culturing	NULL
with	NULL
human	NULL
leukemic	NULL
T-cells	NULL
.	NULL

Gann	NULL
,	NULL
72	NULL
,	NULL
978-981	NULL
(	NULL
1981	NULL
)	NULL
.	NULL

Tanaka	NULL
,	NULL
Y.	NULL
,	NULL
Inoi	NULL
,	NULL
T.	NULL
,	NULL
Tozawa	NULL
,	NULL
H.	NULL
,	NULL
Yamamoto	NULL
,	NULL
N.	NULL
and	NULL
Hinuma	NULL
,	NULL
Y	NULL
.	NULL

A	NULL
glycoprotein	NULL
antigen	NULL
detected	NULL
with	NULL
new	NULL
monoclonal	NULL
antibodies	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
human	NULL
lymphocytes	NULL
infected	NULL
with	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type-I	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
36	NULL
,	NULL
549-555	NULL
(	NULL
1985	NULL
)	NULL
.	NULL

Ishikawa	NULL
,	NULL
K.	NULL
,	NULL
Fukasawa	NULL
,	NULL
M.	NULL
,	NULL
Tsujimoto	NULL
,	NULL
M.	NULL
,	NULL
Else	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Isahakia	NULL
,	NULL
M.	NULL
,	NULL
Ubhi	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
Ishida	NULL
,	NULL
T.	NULL
,	NULL
Takenaka	NULL
,	NULL
O.	NULL
,	NULL
Kawamoto	NULL
,	NULL
Y.	NULL
,	NULL
Shotake	NULL
,	NULL
T.	NULL
,	NULL
Ohsawa	NULL
,	NULL
H.	NULL
,	NULL
Ivanoff	NULL
,	NULL
B.	NULL
,	NULL
Cooper	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Frost	NULL
,	NULL
E.	NULL
,	NULL
Grant	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
Spriatna	NULL
,	NULL
Y.	NULL
,	NULL
Abe	NULL
,	NULL
29	NULL
)	NULL
30	NULL
)	NULL
31	NULL
)	NULL
32	NULL
)	NULL
33	NULL
)	NULL
34	NULL
)	NULL
35	NULL
)	NULL
36	NULL
)	NULL
Heterogeneity	NULL
of	NULL
tax	NULL
Antigen	NULL
Molecules	NULL
K.	NULL
,	NULL
Yamamoto	NULL
,	NULL
K.	NULL
and	NULL
Hayami	NULL
,	NULL
M.	NULL
Serological	NULL
survey	NULL
and	NULL
virus	NULL
isolation	NULL
of	NULL
simian	NULL
T-cell	NULL
leukemia/T-lym-photropic	NULL
virus	NULL
type-I	NULL
(	NULL
STLV-I	NULL
)	NULL
in	NULL
non-human	NULL
primates	NULL
in	NULL
their	NULL
native	NULL
countries	NULL
.	NULL

Int	NULL
J	NULL
.	NULL

Cancer	NULL
,	NULL
40	NULL
,	NULL
233-239	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

Clapham	NULL
,	NULL
P.	NULL
,	NULL
Nagy	NULL
,	NULL
K.	NULL
and	NULL
Weiss	NULL
,	NULL
R.	NULL
A.	NULL
Pseudotypes	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
types	NULL
1	NULL
and	NULL
2	NULL
:	NULL
neutralization	NULL
by	NULL
patients	NULL
's	NULL
sera	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
81	NULL
,	NULL
2886-2889	NULL
(	NULL
1984	NULL
)	NULL
.	NULL

Tanaka	NULL
,	NULL
Y.	NULL
,	NULL
Lee	NULL
,	NULL
B.	NULL
,	NULL
Inoi	NULL
,	NULL
T.	NULL
,	NULL
Tozawa	NULL
,	NULL
H.	NULL
,	NULL
Yamamoto	NULL
,	NULL
N.	NULL
and	NULL
Hinuma	NULL
,	NULL
Y.	NULL
Antigens	NULL
related	NULL
to	NULL
three	NULL
core	NULL
proteins	NULL
of	NULL
HTLV-I	NULL
(	NULL
p24	NULL
,	NULL
p19	NULL
and	NULL
p15	NULL
)	NULL
and	NULL
their	NULL
intracellular	NULL
local-izations	NULL
,	NULL
as	NULL
defined	NULL
by	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

Int	NULL
J	NULL
.	NULL

Cancer	NULL
,	NULL
37	NULL
,	NULL
35-42	NULL
(	NULL
1986	NULL
)	NULL
.	NULL

Manson	NULL
,	NULL
D.	NULL
Y.	NULL
,	NULL
Cordell	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Abdulaziz	NULL
,	NULL
Z.	NULL
,	NULL
Naim	NULL
,	NULL
H.	NULL
and	NULL
Bordenave	NULL
,	NULL
G.	NULL
Preparation	NULL
of	NULL
peroxidase	NULL
:	NULL
antiperox-idase	NULL
(	NULL
PAP	NULL
)	NULL
complexes	NULL
for	NULL
immunchistological	NULL
labeling	NULL
of	NULL
monsclonal	NULL
antibodies	NULL
.	NULL

J.	NULL
Histochem	NULL
.	NULL

Cytochem	NULL
.	NULL

,	NULL
30	NULL
,	NULL
1114-1122	NULL
(	NULL
1982	NULL
)	NULL
,	NULL
Tanaka	NULL
,	NULL
Y.	NULL
,	NULL
Tozawa	NULL
,	NULL
H.	NULL
,	NULL
Koyanagi	NULL
,	NULL
Y.	NULL
,	NULL
Yamamoto	NULL
,	NULL
N.	NULL
and	NULL
Hinuma	NULL
,	NULL
Y	NULL
.	NULL

A	NULL
new	NULL
monoclonal	NULL
antibody	NULL
recognizing	NULL
an	NULL
antigen	NULL
of	NULL
human	NULL
lymphocytes	NULL
similar	NULL
or	NULL
identical	NULL
to	NULL
Tac	NULL
antigen	NULL
.	NULL

Microbiol	NULL
,	NULL
Immunol	NULL
.	NULL

,	NULL
28	NULL
,	NULL
1041-1055	NULL
(	NULL
1984	NULL
)	NULL
.	NULL

Jeang	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
Giam	NULL
,	NULL
C.	NULL
Z.	NULL
,	NULL
Nerenberg	NULL
,	NULL
M.	NULL
and	NULL
Khoury	NULL
,	NULL
G.	NULL
Abundant	NULL
synthesis	NULL
of	NULL
functional	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
p40	NULL
``	NULL
protein	NULL
in	NULL
eucaryotic	NULL
cells	NULL
by	NULL
using	NULL
a	NULL
baculovirus	NULL
expression	NULL
vector	NULL
.	NULL

J.	NULL
Firol	NULL
,	NULL
61	NULL
,	NULL
708-713	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

Nyunoya	NULL
,	NULL
H.	NULL
,	NULL
Akagi	NULL
,	NULL
T.	NULL
,	NULL
Ogura	NULL
,	NULL
T.	NULL
,	NULL
Maeda	NULL
,	NULL
S.	NULL
and	NULL
Shimotohno	NULL
,	NULL
K.	NULL
Evidence	NULL
for	NULL
phosphorylation	NULL
of	NULL
trans	NULL
activator	NULL
p40®	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
produced	NULL
in	NULL
insect	NULL
cells	NULL
with	NULL
a	NULL
baculovirus	NULL
expression	NULL
vector	NULL
.	NULL

Firology	NULL
,	NULL
167	NULL
,	NULL
538-544	NULL
(	NULL
1988	NULL
)	NULL
.	NULL

Watanabe	NULL
,	NULL
T.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Tsujimoto	NULL
,	NULL
H.	NULL
,	NULL
Miyoshi	NULL
,	NULL
L	NULL
,	NULL
Hayami	NULL
,	NULL
M.	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
Sequence	NULL
homology	NULL
of	NULL
the	NULL
simian	NULL
retrovirus	NULL
(	NULL
STLV-I	NULL
)	NULL
genome	NULL
with	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type-I	NULL
(	NULL
HTLV-I	NULL
)	NULL
.	NULL

Virology	NULL
,	NULL
144	NULL
,	NULL
59-65	NULL
(	NULL
1985	NULL
)	NULL
.	NULL

Watanabe	NULL
,	NULL
T.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Hirayama	NULL
,	NULL
Y.	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
African	NULL
subtype	NULL
of	NULL
simian	NULL
viruses	NULL
(	NULL
STLY	NULL
)	NULL
.	NULL

Firology	NULL
,	NULL
148	NULL
,	NULL
385-388	NULL
(	NULL
1986	NULL
)	NULL
.	NULL

231	NULL

